On the detail: content assay requires a reference standard of known purity and traceability, which is why it costs more than purity testing does.
For peptides at 214 nanometres the response is roughly proportional to the number of peptide bonds, so truncation impurities have lower response factors and overestimate content.
If a sample shows high purity but low content, the explanation is usually that the standard used for quantitation had a different purity than claimed.
Pharmacopoeial guidance on quantitative methods specifies validation steps for linearity, range, accuracy and precision that most research-grade work does not claim to meet.
One qualification: a single result from a single vial is a point estimate, and repeating the assay on a second aliquot is worth doing if the first result is surprising.
If a supplier gives you content without the standard's purity, ask them to provide it.
edited 1 Nov 2024 by Dr_Elias_Weiss — added the method parameters
7This is the first explanation of that which has actually made sense to me. – loss_on_drying 17 days ago 8Note that the label instructions differ between agents on precisely this point. – stopper_core 2 months ago add a comment